Effectiveness and Safety of Valsartan in Children Aged 6 to 16 Years With Hypertension
Authors:
- Jeffrey BlumerJBJeffrey Blumer
- Mieczysław LitwinMLMieczysław Litwin
- The Valsartan Pediatric Hypertension Study GroupTGThe Valsartan Pediatric Hypertension Study Group
- 18 March 2011
- journal article
- research article
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 13 (5) , 357-365
Abstract
The effectiveness and safety of valsartan have not been assessed in hypertensive children. Therefore, hypertensive patients aged 6 to 16 years (n=261) were randomized to receive weight‐stratified low‐ (10/20 mg), medium‐ (40/80 mg), or high‐dose (80/160 mg) valsartan for 2 weeks. After 2 weeks, patients were randomized to a 2‐week placebo‐controlled withdrawal phase. Dose‐dependent reductions in sitting systolic blood pressure (SSBP) and sitting diastolic blood pressure (SDBP) were observed after 2 weeks (low dose, −7.9/−4.6 mm Hg; medium dose, −9.6/−5.8 mm Hg; high dose, −11.5/−7.4 mm Hg [P<.0001 for all groups]). During the withdrawal phase, SSBP and SDBP were both lower in the pooled valsartan group than in the pooled placebo group (SSBP, −2.7 mm Hg [P=.0368]; SDBP, −3.0 mm Hg [P=.0047]). Similar efficacy was observed in all subgroups. Valsartan was well tolerated and headache was the most commonly observed adverse event during both the double‐blind and 52‐week open‐label phases. J Clin Hypertens (Greenwich). 2011;13:357–365. ©2011 Wiley Periodicals, Inc.Keywords
This publication has 31 references indexed in Scilit:
- Hypertension in children and adolescents: epidemiology and natural historyPediatric Nephrology, 2009
- Blood Pressure in Children With Chronic Kidney DiseaseHypertension, 2008
- Pediatric Antihypertensive Trial FailuresHypertension, 2008
- Hypertension in children: an update on treatment strategiesCurrent Opinion in Pediatrics, 2007
- Pharmacologic treatment of hypertension in children and adolescentsThe Journal of Pediatrics, 2006
- Treatment of primary and secondary hypertension in childrenPediatric Nephrology, 2006
- White-coat and masked hypertension in children: association with target-organ damagePediatric Nephrology, 2005
- Summary of the Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and AdolescentsHypertension, 2004
- A randomized, placebo-controlled trial of amlodipine in children with hypertensionThe Journal of Pediatrics, 2004
- A Double‐Blind, Placebo‐Controlled, Dose‐Response Study of the Effectiveness and Safety of Enalapril for Children with HypertensionThe Journal of Clinical Pharmacology, 2002